The Impact of Lifestyle in Breast Cancer Risk and Recurrence:
Julia Palmer, Mary Beth Terry, and Kristy Brown will address this topic in a special session at #SABCS25 (December 9-12). Learn more:
buff.ly/gODonOd
@drkristyabrown.bsky.social
@sabcs.bsky.social
SABCS is the world's largest gathering of doctors, researchers and scientists sharing state-of-the-art information on experimental biology, etiology, prevention, diagnosis, and therapy for breast cancer and premalignant breast diseases. www.sabcs.org
The Impact of Lifestyle in Breast Cancer Risk and Recurrence:
Julia Palmer, Mary Beth Terry, and Kristy Brown will address this topic in a special session at #SABCS25 (December 9-12). Learn more:
buff.ly/gODonOd
@drkristyabrown.bsky.social
Individual Housing Deadline: November 17β
Make your hotel reservations for #SABCS25 now and join us in San Antonio December 9-12. Learn more:
buff.ly/GC6SiN6
Submit a late-breaking abstract by September 30 and share your work with the breast cancer research community at #SABCS25 (December 9-12). Learn more:
buff.ly/xCP2nj0
The #SABCS25 Early Registration deadline is September 26. Register now and be a part of the world's premier breast cancer meeting, December 9-12. Learn more:
buff.ly/8ow62kS
ADCs in the Clinic:
Sibylle Loibl, Reshma Mahtani, and Andrew Brenner will address this topic in an educational session at #SABCS25 (December 9-12). Learn more:
buff.ly/yLCM27r
@mahtanimiami.bsky.social
Do All Early-stage Breast Cancer Patients Need Axillary Staging?
Melissa Pilewskie and Peter Dubsky will debate this question in a special session at #SABCS25 (December 9-12). Learn more:
buff.ly/MwgwoAH
@breastdoktor.bsky.social
Evidence That ADCs Are Target Therapy:
Sarat Chandarlapaty will address this topic in a Translational Controversies session at #SABCS25 (December 9-12). Learn more:
buff.ly/H4yU6LT
@saratchandarlapaty.bsky.social
Register by September 26 to get the lowest rates for #SABCS25 and join the breast cancer community in San Antonio December 9-12. Learn more:
buff.ly/8ow62kS
The late-breaking abstract deadline for #SABCS25 is September 30. Submit an abstract today and join us December 9-12 for the most important breast cancer meeting in the world. Learn more:
buff.ly/xCP2nj0
Breast Cancer in Young Women: When, Why, and How?
Melissa Troester, Kornelia Polyak, and Sherene Loi will address this question in an educational session at #SABCS25 (December 9-12). Learn more:
buff.ly/OB6T5Xs
@loisher.bsky.social
Housing is now open for #SABCS25 (December 9-12). Make your reservations now to secure the best available hotels. Learn more:
buff.ly/GC6SiN6
Clinical Controversies: Management of the Axillaβ
Giacomo Montagna, Lori Pierce, and Sherry Shen will address this topic in a special session at #SABCS25 (December 9-12). Learn more:
buff.ly/ykgbF15
@sherryshenmd.bsky.social
Late-breaking abstract submission is now open for the San Antonio Breast Cancer Symposium, December 9-12, 2025.
Abstract deadline: September 30. Learn more:
buff.ly/xCP2nj0
#SABCS25
Refining Local Therapy in Multi-disciplinary Care:
Chelain Goodman, Birgitte Offersen, and Justin Broyles will address this topic in an educational session at #SABCS25 (December 9-12). Learn more:
buff.ly/UNuCF3a
@chelaing.bsky.social
Register by September 26 to get the lowest rates for #SABCS25 (December 9-12). Learn more:
buff.ly/8ow62kS
Balancing Act: Hormone Replacement Therapy in Breast Cancer Careβ
Maryam Lustberg, Juliana Kling, and Lisa Larkin will address this topic in an educational session at #SABCS25 (December 9-12). Learn more:
buff.ly/kGVp0C7
@maryamlustberg.bsky.social @lisalarkinmd.bsky.social
The #SABCS25 Early Registration deadline is September 26. Register now and be a part of the world's premier breast cancer meeting, December 9-12. Learn more:
buff.ly/8ow62kS
Liquid Biopsy for Adaptive Therapy in Breast Cancer:
Angela DeMichele, Michail Ignatiadis, and FranΓ§ois-ClΓ©ment Bidard will address this topic in a State of the Art Session at #SABCS25 (December 9-12). Learn more:
buff.ly/XHH8tgH
@mignatiadis.bsky.social
Genetic and Epigenetic Determinants of BRCA1/2 Tumorigenesis:
Joan Brugge will address this topic in a plenary lecture at #SABCS25 (December 9-12). Learn more:
sabcs.org/FullProgram/...
Take a look back at #SABCS24! Thank you to the co-directors, executive committee, program planning committee, speakers, and attendees for making this year's symposium a tremendous success.
@uthealthsamda.bsky.social @theaacr.bsky.social
@vkaklamani.bsky.social talking with advocates in the βHot Topicsβ session at @sabcs.bsky.social
13.12.2024 18:58 β π 9 π 2 π¬ 0 π 0The #SABCS24 Spotlight series features conversations with scientists, clinicians, survivors, and advocates sharing their experiences from @sabcs.bsky.social the world's most comprehensive meeting on breast cancer research and treatment. www.youtube.com/playlist?lis...
12.12.2024 17:39 β π 5 π 1 π¬ 0 π 0Advocacy makes a difference π
A week ago I shared w/ Dr. Alistair Thompson that "right-sizing treatment" is preferred terminology to "de-escalation." Latter can imply 'less than" which, in absence of strong health/disease literacy, can be terrifying.
Today he shared that info his #SABCS24 preso
Ian Kunkler presenting on the SUPRIMO Trial at @sabcs.bsky.social
12.12.2024 15:46 β π 3 π 1 π¬ 0 π 0Todayβs #SABCS24 press conference featured tamoxifen for patients who forgo radiation after DCIS surgery, active monitoring in DCIS, chest wall irradiation after mastectomy, and adding palbociclib for HER2-positive breast cancer: www.aacr.org/about-the-aa...
12.12.2024 14:16 β π 5 π 1 π¬ 1 π 0Dr. Erika Mayer of @dfcibreastonc.bsky.social answering questions following her presentation about CDK4-6 inhibitors to patient advocates. Carrie Treadwell of @theaacr.bsky.social is moderating. @sabcs.bsky.social
11.12.2024 19:02 β π 8 π 3 π¬ 0 π 0Join our collaborators at @vjoncology.bsky.social during #SABCS24 , as they bring you the latest trial data and expert insights on breast cancer. Stay tuned for our comprehensive coverage of the event!
https://bit.ly/48P9tCd
#SABCS24 Preview: Nobel Laureate William G. Kaelin, Jr., MD, will deliver the keynote address at 8:35 am CT this morning. Learn more in SABCS Meeting News: www.sabcsmeetingnews.org/nobel-prize-...
11.12.2024 13:09 β π 4 π 0 π¬ 0 π 0#SABCS24 Day 1 Highlights #CommunityOnc:
1. @FDAOncology Reviews recent approvals: #Ribociclib & #Inavolisib
2. #PADMA: HR+ ET + CDK4/6i vs Chemo 1L
3. #DB06: HR+ TDXd
4. #KN522: biomarker analysis
#OncSky #CanSky @sabcs.bsky.social @drsarahsammons.bsky.social @dr-rshatsky.bsky.social
1/5